更正：在最后一次免疫接种4年后进行晚期MVA-B加强免疫后，健康志愿者的安全性及疫苗诱导的HIV-1免疫反应。
Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
作者信息
Guardo Alberto C, Gómez Carmen Elena, Díaz-Brito Vicens, Pich Judit, Arnaiz Joan Albert, Perdiguero Beatriz, García-Arriaza Juan, González Nuria, Sorzano Carlos O S, Jiménez Laura, Jiménez José Luis, Muñoz-Fernández María Ángeles, Gatell José M, Alcamí José, Esteban Mariano, de Quirós Juan Carlos López Bernaldo, García Felipe, Plana Montserrat
出版信息
PLoS One. 2018 Apr 10;13(4):e0195915. doi: 10.1371/journal.pone.0195915. eCollection 2018.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0186602.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0186602。]
相似文献
1
Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.更正：在最后一次免疫接种4年后进行晚期MVA-B加强免疫后，健康志愿者的安全性及疫苗诱导的HIV-1免疫反应。
PLoS One. 2018 Apr 10;13(4):e0195915. doi: 10.1371/journal.pone.0195915. eCollection 2018.
2
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.在最后一次免疫接种4年后进行晚期MVA-B加强免疫后，健康志愿者的安全性及疫苗诱导的HIV-1免疫反应。
PLoS One. 2017 Oct 24;12(10):e0186602. doi: 10.1371/journal.pone.0186602. eCollection 2017.
3
HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.在健康的瑞典HIV-1 DNA/MVA疫苗接种者中，联合或不联合皮内电穿孔给予HIV-DNA是安全且具有高度免疫原性的：一项I期随机试验。
PLoS One. 2015 Jun 29;10(6):e0131748. doi: 10.1371/journal.pone.0131748. eCollection 2015.
4
A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen.一种与痘苗病毒14K（A27）蛋白融合的嵌合HIV-1 gp120作为HIV免疫原。
PLoS One. 2015 Jul 24;10(7):e0133595. doi: 10.1371/journal.pone.0133595. eCollection 2015.
5
A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.一种多基因1型人类免疫缺陷病毒C亚型改良安卡拉痘苗（MVA）疫苗可有效增强小鼠对DNA疫苗的免疫反应。
AIDS Res Hum Retroviruses. 2008 Feb;24(2):207-17. doi: 10.1089/aid.2007.0206.
6
A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice.一种新型多分支DNA初免/重组痘苗病毒安卡拉加强疫苗在小鼠中诱导出广泛且高水平的HIV-1特异性CD8(+) T细胞和体液免疫反应。
Mol Ther. 2007 Sep;15(9):1724-33. doi: 10.1038/sj.mt.6300235. Epub 2007 Jun 19.
7
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.C亚型gp140疫苗在间隔超过2年后增强了由南非艾滋病疫苗倡议组织的DNA-C2和MVA-C艾滋病毒疫苗引发的免疫反应。
Clin Vaccine Immunol. 2016 Jun 6;23(6):496-506. doi: 10.1128/CVI.00717-15. Print 2016 Jun.
8
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.基于减毒痘病毒株MVA和NYVAC在单个位点共表达HIV-1 BX08 gp120和B亚型HIV-1（IIIB）Gag-Pol-Nef蛋白的两种HIV/AIDS候选疫苗免疫原性的直接比较。
Vaccine. 2007 Apr 12;25(15):2863-85. doi: 10.1016/j.vaccine.2006.09.090. Epub 2006 Oct 16.
9
Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.RV144 艾滋病疫苗有效性试验中未感染 HIV 的疫苗接种者晚期加强策略的随机双盲评估
J Infect Dis. 2017 Apr 15;215(8):1255-1263. doi: 10.1093/infdis/jix099.
10
Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.新型腺病毒 26 型和改良安卡拉痘苗病毒载体埃博拉疫苗的安全性和免疫原性：一项随机临床试验。
JAMA. 2016 Apr 19;315(15):1610-23. doi: 10.1001/jama.2016.4218.
引用本文的文献
1
A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.一种新型基于 MVA 的 HIV 疫苗候选物（MVA-gp145-GPN），共表达 C 型膜结合三聚体 gp145Env 和 Gag 诱导的病毒样颗粒（VLPs），引发广泛的多功能 HIV-1 特异性 T 细胞和抗体反应。
Viruses. 2019 Feb 16;11(2):160. doi: 10.3390/v11020160.
本文引用的文献
1
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.在最后一次免疫接种4年后进行晚期MVA-B加强免疫后，健康志愿者的安全性及疫苗诱导的HIV-1免疫反应。
PLoS One. 2017 Oct 24;12(10):e0186602. doi: 10.1371/journal.pone.0186602. eCollection 2017.
Zotero 插件